| Product Code: ETC11489382 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Saudi Arabia Cannabis Pharmaceuticals Market Overview |
3.1 Saudi Arabia Country Macro Economic Indicators |
3.2 Saudi Arabia Cannabis Pharmaceuticals Market Revenues & Volume, 2021 & 2031F |
3.3 Saudi Arabia Cannabis Pharmaceuticals Market - Industry Life Cycle |
3.4 Saudi Arabia Cannabis Pharmaceuticals Market - Porter's Five Forces |
3.5 Saudi Arabia Cannabis Pharmaceuticals Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Saudi Arabia Cannabis Pharmaceuticals Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Saudi Arabia Cannabis Pharmaceuticals Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Saudi Arabia Cannabis Pharmaceuticals Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.9 Saudi Arabia Cannabis Pharmaceuticals Market Revenues & Volume Share, By Benefit, 2021 & 2031F |
4 Saudi Arabia Cannabis Pharmaceuticals Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing acceptance of medical cannabis for various health conditions in Saudi Arabia |
4.2.2 Government initiatives to explore the potential of cannabis pharmaceuticals for medical use |
4.2.3 Growing investments in research and development of cannabis-based pharmaceutical products |
4.3 Market Restraints |
4.3.1 Regulatory challenges and strict laws surrounding the use of cannabis in Saudi Arabia |
4.3.2 Limited awareness and education among healthcare professionals and patients about cannabis pharmaceuticals |
4.3.3 Cultural and societal stigma associated with cannabis use in the region |
5 Saudi Arabia Cannabis Pharmaceuticals Market Trends |
6 Saudi Arabia Cannabis Pharmaceuticals Market, By Types |
6.1 Saudi Arabia Cannabis Pharmaceuticals Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Saudi Arabia Cannabis Pharmaceuticals Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 Saudi Arabia Cannabis Pharmaceuticals Market Revenues & Volume, By Capsules, 2021 - 2031F |
6.1.4 Saudi Arabia Cannabis Pharmaceuticals Market Revenues & Volume, By Oils, 2021 - 2031F |
6.1.5 Saudi Arabia Cannabis Pharmaceuticals Market Revenues & Volume, By Topicals, 2021 - 2031F |
6.2 Saudi Arabia Cannabis Pharmaceuticals Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Saudi Arabia Cannabis Pharmaceuticals Market Revenues & Volume, By Pain Management, 2021 - 2031F |
6.2.3 Saudi Arabia Cannabis Pharmaceuticals Market Revenues & Volume, By Anxiety Relief, 2021 - 2031F |
6.2.4 Saudi Arabia Cannabis Pharmaceuticals Market Revenues & Volume, By Skin Conditions, 2021 - 2031F |
6.3 Saudi Arabia Cannabis Pharmaceuticals Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Saudi Arabia Cannabis Pharmaceuticals Market Revenues & Volume, By Patients, 2021 - 2031F |
6.3.3 Saudi Arabia Cannabis Pharmaceuticals Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.4 Saudi Arabia Cannabis Pharmaceuticals Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4 Saudi Arabia Cannabis Pharmaceuticals Market, By Source |
6.4.1 Overview and Analysis |
6.4.2 Saudi Arabia Cannabis Pharmaceuticals Market Revenues & Volume, By Cannabis-Based, 2021 - 2031F |
6.4.3 Saudi Arabia Cannabis Pharmaceuticals Market Revenues & Volume, By Hemp-Based, 2021 - 2031F |
6.4.4 Saudi Arabia Cannabis Pharmaceuticals Market Revenues & Volume, By Plant-Based, 2021 - 2031F |
6.5 Saudi Arabia Cannabis Pharmaceuticals Market, By Benefit |
6.5.1 Overview and Analysis |
6.5.2 Saudi Arabia Cannabis Pharmaceuticals Market Revenues & Volume, By Non-Psychoactive, 2021 - 2031F |
6.5.3 Saudi Arabia Cannabis Pharmaceuticals Market Revenues & Volume, By Natural, 2021 - 2031F |
6.5.4 Saudi Arabia Cannabis Pharmaceuticals Market Revenues & Volume, By Anti-Inflammatory, 2021 - 2031F |
7 Saudi Arabia Cannabis Pharmaceuticals Market Import-Export Trade Statistics |
7.1 Saudi Arabia Cannabis Pharmaceuticals Market Export to Major Countries |
7.2 Saudi Arabia Cannabis Pharmaceuticals Market Imports from Major Countries |
8 Saudi Arabia Cannabis Pharmaceuticals Market Key Performance Indicators |
8.1 Number of clinical trials and research studies conducted on cannabis pharmaceuticals in Saudi Arabia |
8.2 Percentage increase in the number of healthcare professionals trained in prescribing cannabis-based medications |
8.3 Growth in the number of licensed pharmaceutical companies developing cannabis-based products in Saudi Arabia |
9 Saudi Arabia Cannabis Pharmaceuticals Market - Opportunity Assessment |
9.1 Saudi Arabia Cannabis Pharmaceuticals Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Saudi Arabia Cannabis Pharmaceuticals Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Saudi Arabia Cannabis Pharmaceuticals Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Saudi Arabia Cannabis Pharmaceuticals Market Opportunity Assessment, By Source, 2021 & 2031F |
9.5 Saudi Arabia Cannabis Pharmaceuticals Market Opportunity Assessment, By Benefit, 2021 & 2031F |
10 Saudi Arabia Cannabis Pharmaceuticals Market - Competitive Landscape |
10.1 Saudi Arabia Cannabis Pharmaceuticals Market Revenue Share, By Companies, 2024 |
10.2 Saudi Arabia Cannabis Pharmaceuticals Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here